MEDVi vs Mochi Health: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent research·How we rank →

MEDVi and Mochi Health are tied at 7.7/10. Mochi Health is more affordable at $178/mo vs $299/mo. Choose MEDVi for users who want a low entry price with oral and injectable co. Choose Mochi Health for users who want a tech-forward platform with app-based tracki.

A side-by-side comparison of MEDVi and Mochi Health covering pricing, scores, medication types, insurance, and more to help you decide.

MEDVi

#22 of 48

7.7/10

MEDVi is a compounded GLP-1 telehealth platform offering both oral tablets and injectable semaglutide and tirzepatide, with micro-dosing options for side-effect-sensitive patients. $179/mo entry pricing, free shipping, and a streamlined intake — one of the broader compounded mixes among independent telehealth providers in 2026.

Visit MEDVi

Mochi Health

#20 of 48

7.7/10

Tech-forward GLP-1 platform with a sleek app for tracking progress, medications, and provider communications.

Visit Mochi Health

Feature	MEDVi	Mochi Health
Our Score	7.7/10	7.7/10
Starting Price	$299/mo	$178/mo
Medication Type	Both	Compounded
Insurance Accepted	No	No
Best For	Users who want a low entry price with oral and injectable compounded options	Users who want a tech-forward platform with app-based tracking
Ranking	#22	#20

Pros & Cons Compared

MEDVi

Pros

+One of the few compounded providers offering both oral tablets and injectable semaglutide
+Micro-dosing options available — can start at sub-standard doses for patients concerned about side effects
+Sleek onboarding experience with clear progress tracking through their patient portal
+$179/mo is competitive for a platform with both oral and injectable compounded formulations

Cons

−Compounded medications only — no path to brand-name Wegovy or Zepbound through their platform
−No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms

Mochi Health

Pros

+Flat $99/mo semaglutide at ALL dose levels — saves $100-200/mo vs competitors who charge more at higher doses
+4 semaglutide formats: injection, oral tablet, oral drops, and microdose — the most delivery options of any platform
+Registered dietitians included alongside physicians — not just medication, but nutritional support
+Both compounded and brand-name medications available (Ozempic, Wegovy, Mounjaro, Zepbound, Rybelsus)

Cons

−Separate $79/mo membership fee makes the real cost ~$178/mo for semaglutide, not the advertised $99
−No refunds for payments made over 30 days ago — limited consumer protection window
−Relatively new company (founded 2022) with less track record than established platforms

Our Verdict

MEDVi and Mochi Health are closely matched with identical scores of 7.7/10. If budget is your priority, Mochi Health starts at $178/mo compared to MEDVi's $299/mo. MEDVi offers both brand-name and compounded medications, giving you more flexibility. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options. Choose Mochi Health if you want: users who want a tech-forward platform with app-based tracking.

Still undecided? Editor's #1 Overall Pick

Eden Health GLP-1

$249/mo · 8.9/10 · Both

If neither MEDVi nor Mochi Health feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Eden Health GLP-1 — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Eden Health GLP-1→Read our full Eden Health GLP-1 review